Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Seriously, I am really perplexed!

yes the 380 million shares is part of it, but there is also fear that we loose the court case. If that happens we sink.

No long term profit , patents are being sold for one time fee.

We win in TX, we start selling deals for larger amounts and with royalties that continue(not one timers). We start another revenue stream that is profitable. We get off the OTC. .......on and on.

Right now we just have half of smaller deals that are one timers and we';ve spent the cash, and only have part of a Holcom deal.

Fear of that is all there is keeps the price down, and btw, if all that gets better, then the 380 million shares will be needed for funds to buy in and to make a huge market.

It will come in time.

Share
New Message
Please login to post a reply